Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.
Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy.
Recruiting · NCT07585981 · Registry updated 2026-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Application of Budesonide Enteric-coated Capsules in the Treatment of Primary IgA Nephropathy. | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Recruiting | Not stated | 2026-05-14 | NCT07585981 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chinese PLA General Hospital | 238 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese PLA General Hospital | Beijing | China | 39 |